Goldman Sachs Group Inc Royalty Pharma PLC Transaction History

Goldman Sachs Group Inc

$596 Billion
Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Goldman Sachs Group Inc holds 419,234 shares of RPRX stock, worth $14.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

419,234

Previous 419,234 -0.0%

Holding current value

$14.1 Million

Previous $13.1 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$25.75 - $33.86 $3.78 Million - $4.97 Million	-146,917 Reduced 25.95%	419,234 $13.1 Million
Q4 2024 Feb 11, 2025	BUY	$24.28 - $28.39 $2.32 Million - $2.72 Million	95,732 Added 20.35%	566,151 $14.4 Million
Q3 2024 Nov 14, 2024	BUY	$25.63 - $29.27 $3.88 Million - $4.43 Million	151,237 Added 47.38%	470,419 $13.3 Million
Q2 2024 Aug 13, 2024	SELL	$26.26 - $29.9 $7.45 Million - $8.49 Million	-283,806 Reduced 47.07%	319,182 $8.42 Million
Q1 2024 May 15, 2024	SELL	$27.46 - $31.33 $62.2 Million - $71 Million	-2,266,558 Reduced 78.99%	602,988 $18.3 Million
Q4 2023 Feb 13, 2024	SELL	$26.21 - $29.22 $35.1 Million - $39.2 Million	-1,340,649 Reduced 31.84%	2,869,546 $80.6 Million
Q3 2023 May 14, 2024	BUY	$26.26 - $31.38 $35.2 Million - $42.1 Million	1,340,649 Added 46.72%	4,210,195 $114 Million
Q3 2023 Nov 14, 2023	BUY	$26.26 - $31.38 $14.8 Million - $17.7 Million	563,139 Added 15.44%	4,210,195 $114 Million
Q2 2023 May 14, 2024	BUY	$29.6 - $36.56 $39.8 Million - $49.1 Million	1,343,711 Added 58.34%	3,647,056 $112 Million
Q2 2023 Aug 14, 2023	BUY	$29.6 - $36.56 $39.8 Million - $49.1 Million	1,343,711 Added 58.34%	3,647,056 $112 Million
Q1 2023 May 14, 2024	BUY	$32.77 - $39.4 $35.5 Million - $42.6 Million	1,081,886 Added 88.57%	2,303,345 $83 Million
Q1 2023 May 11, 2023	BUY	$32.77 - $39.4 $35.5 Million - $42.6 Million	1,081,886 Added 88.57%	2,303,345 $83 Million
Q4 2022 May 14, 2024	SELL	$39.17 - $44.04 $6.08 Million - $6.84 Million	-155,246 Reduced 11.28%	1,221,459 $48.3 Million
Q4 2022 Feb 13, 2023	SELL	$39.17 - $44.04 $6.08 Million - $6.84 Million	-155,246 Reduced 11.28%	1,221,459 $48.3 Million
Q3 2022 May 14, 2024	BUY	$39.88 - $44.65 $15.6 Million - $17.4 Million	390,178 Added 39.55%	1,376,705 $55.3 Million
Q3 2022 Nov 10, 2022	BUY	$39.88 - $44.65 $15.6 Million - $17.4 Million	390,178 Added 39.55%	1,376,705 $55.3 Million
Q2 2022 May 14, 2024	SELL	$37.53 - $44.22 $70.7 Million - $83.3 Million	-1,883,019 Reduced 65.62%	986,527 $41.5 Million
Q2 2022 Aug 15, 2022	SELL	$37.53 - $44.22 $15.1 Million - $17.7 Million	-401,103 Reduced 28.91%	986,527 $41.5 Million
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $3.08 Million - $3.48 Million	82,110 Added 6.29%	1,387,630 $54.1 Million
Q4 2021 Feb 14, 2022	BUY	$35.17 - $42.48 $14.4 Million - $17.3 Million	408,117 Added 45.48%	1,305,520 $52 Million
Q3 2021 Nov 10, 2021	BUY	$36.14 - $42.24 $32.4 Million - $37.9 Million	897,403 New	897,403 $32.4 Million

Others Institutions Holding RPRX

# of Institutions

484

Shares Held

283M

Call Options Held

2.51M

Put Options Held

941K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $14.8B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Royalty Pharma PLC Transaction History